FRSLX
Price
$28.09
Change
-$0.22 (-0.78%)
Updated
Oct 7 closing price
Net Assets
169.97M
PMBPX
Price
$45.52
Change
-$0.32 (-0.70%)
Updated
Oct 7 closing price
Net Assets
33.08B
Interact to see
Advertisement

FRSLX vs PMBPX

Header iconFRSLX vs PMBPX Comparison
Open Charts FRSLX vs PMBPXBanner chart's image
Nuveen Small/Mid Cap Growth Opp A
Price$28.09
Change-$0.22 (-0.78%)
VolumeN/A
Net Assets169.97M
Principal MidCap R5
Price$45.52
Change-$0.32 (-0.70%)
VolumeN/A
Net Assets33.08B
FRSLX vs PMBPX Comparison Chart in %
View a ticker or compare two or three
VS
FRSLX vs. PMBPX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRSLX is a Buy and PMBPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 33.1B vs. FRSLX (170M). PMBPX pays higher dividends than FRSLX: PMBPX (0.01) vs FRSLX (0.00). FRSLX was incepted earlier than PMBPX: FRSLX (31 years) vs PMBPX (25 years). FRSLX (1.24) is less costly to investors than PMBPX (0.83). FRSLX is a more actively managed with annual turnover of: 58.00 vs. PMBPX (10.50). PMBPX has a lower initial minimum investment than FRSLX: PMBPX (0) vs FRSLX (3000). FRSLX annual gain was more profitable for investors over the last year : 13.15 vs. PMBPX (4.31). PMBPX return over 5 years is better than : 40.37 vs. FRSLX (-20.94).
FRSLXPMBPXFRSLX / PMBPX
Total Expense Ratio1.130.83136%
Annual Report Gross Expense Ratio1.240.83149%
Fund Existence31 years25 years-
Gain YTD7.5205.476137%
Front Load6%N/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets170M33.1B1%
Annual Yield % from dividends0.000.01-
Returns for 1 year13.154.31305%
Returns for 3 years52.7854.8396%
Returns for 5 years-20.9440.37-52%
Returns for 10 years-30.08109.43-27%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHCX92.27N/A
N/A
Rydex Health Care C
SCAYX12.14N/A
N/A
Invesco Income Advantage U.S. Fund Y
LMGFX77.49N/A
N/A
ClearBridge International Growth FI
GCSLX23.88N/A
N/A
Victory Pioneer Global Equity C
CFJAX35.94N/A
N/A
Calvert US Large Cap Value Rspnb Idx A